25 related news articles for

The problems caused by fetal growth restriction (FGR) can persist well beyond birth, and a new study could explain why these babies face higher cardiac risks later in life – revealing how FGR rewires the heart’s metabolism.…  Read more

The dangers to the unborn child caused by Fetal Growth Restriction (FGR) are becoming better understood and now, researchers at Hudson Institute have identified specifically how it impacts brain development.…  Read more

A group of Hudson Institute and Monash University researchers is among the few in the world studying how menstruation – when it starts, its frequency and reliability, and whether it is painful, heavy or light – affects a woman’s likelihood of developing complications in pregnancy.  It’s a rare venture into the potential link between a…  Read more

Neonatologist and clinician-scientist Associate Professor Atul Malhotra from The Ritchie Centre, the School of Clinical Sciences at Monash Health,  and Monash Children’s Hospital,  has been awarded a Fulbright Professional Coral Sea Scholarship to support the US implementation of an umbilical cord blood (UCB) cell therapies clinical trial for extremely preterm babies. …  Read more

Women early in their pregnancy are being recruited for a study looking into the link between their menstrual symptoms and pregnancy complications including preterm birth, fetal growth restriction (FGR) and stillbirth.…  Read more

Dr Emily Camm is now taking a 21st century approach to the placenta’s significance by incorporating Artificial Intelligence (AI)-based analysis to identify the risk of child developmental issues, even before they appear.…  Read more

Babies affected by Fetal Growth Restriction (FGR) have poor cardiorespiratory control; now Hudson Institute researchers have become the first to show persistent injury in the brainstem of growth restricted fetuses as the likely cause. …  Read more

The health effects of fetal growth restriction (FGR) can last a lifetime and the latest research from Hudson Institute is showing just how pervasive those effects can be on the cardiovascular system.…  Read more

Professor Suzanne Miller and her team’s PROTECT Me Trial is providing hope to parents of our most vulnerable babies like Ronick.…  Read more

Professor Suzanne Miller, scientific leader in fetal and neonatal neurodevelopment, has been appointed as the new Head of The Ritchie Centre.…  Read more

Hudson Institute has featured prominently in the Victorian Premier’s Awards for Health and Medical Research, thanks to pioneering work developing new treatments for pelvic organ prolapse (POP).…  Read more

and the function of the placenta, but new research also finds the impacts vary depending on the sex of the child.…  Read more

It’s the most common of all physical disabilities, affecting one in 500 Australians and more than 17 million people worldwide, but there is still so much to learn about Cerebral Palsy. …  Read more

A new study in pre-clinical models has discovered a link between low oxygen in the womb and impaired memory function. It also finds that anti-oxidant supplements during pregnancy may protect against this.…  Read more

A discovery by Hudson Institute researchers sheds light on the potential reasons why exposing unborn babies affected by fetal growth restriction (FGR) to sildenafil may have led to unexpected neonatal deaths.…  Read more

Treatments given postnatally to babies who have experienced fetal growth restriction (FGR) during pregnancy need to be carefully considered, following new light shed on the topic by cell therapy research.…  Read more

Hudson Institute scientists have demonstrated for the first time that umbilical cord stem cells can protect preterm, growth-restricted babies from brain injury.…  Read more

The impact of a serious pregnancy condition that affects millions of unborn babies globally could be minimised by improved imaging techniques.…  Read more

For the first time Hudson Institute researchers have shown how fetal growth restriction (FGR), a condition which may impact brain development for up to one in 10 babies, gradually worsens during pregnancy. …  Read more

Hudson Institute is delighted to announce the success of our researchers in the new NHMRC Investigator Grant round.…  Read more

A world-first clinical trial will see women with fetal growth restriction receive daily doses of melatonin to prevent poor neurological outcomes in babies.…  Read more

Hudson Institute has had excellent success in the recent NHMRC and ARC Grant rounds.…  Read more

Two Hudson Institute scientists, Dr Michelle Tate and Dr Erin McGillick, have been presented with prestigious Victorian Young Tall Poppy Science Awards in recognition of their outstanding research achievements and community engagement.…  Read more

Hudson Institute has had outstanding success in the recent NHMRC Project Grant round. In addition, our researchers have been awarded an NHMRC Partnership Grant, an NHMRC Development Grant, an ARC Discovery Grant and three NMHRC Fellowships.…  Read more

Hudson Institute researchers will work to prevent osteoporosis, protect unborn babies’ brains from damage and harness mitochondrial DNA to give women a better chance of pregnancy, thanks to almost $2 million in funding awarded by Australia’s leading medical research body. The National Health and Medical Research Council (NHMRC) last week announced funding for the research…  Read more